Studies are underway to determine cellular and molecular mechanisms underlying the interactions of natural/synthetic estrogenic compounds with various target tissues (developing genital tract, gonads, liver, mammary and bone tissues) resulting in permanent alterations in differentiation including dysmorphology and neoplasia. DES is used as a model estrogenic compound. In vivo studies in which DES exposure occurs during development (prenatal and/or neonatal) of the genital tract have shown various benign/malignant lesions in male/female mice similar to those reported in humans exposed to DES. Immunocytochemical/molecular genetic characteristics of the DES-induced murine tumors are being compared with those seen in human malignancies. Descendants of tumor- bearing mice are being followed for reproductive assessment and potential increased susceptibility to tumors. The ontogeny of lactoferin (LF), complement C3, decay-accelerating factor (DAF), and the estrogen receptor (ER) in the developing reproductive tract are being mapped in vivo/in vitro to determine early estrogenic responses and the role of ER. Transgenic mice overexpressing the ER have been treated with DES to determine if the ER is playing a role in the induction and/or progression of uterine neoplasia. Dysmorphology in the genital tract of mice exposed to DES includes persistent gene expression of uterine LF and various growth factors including TGF-alpha and EGF which may be preneoplastic markers. Since questions remain concerning the roles of growth factors, growth inhibitors, and receptors, studies continue to identify additional human/mouse genes that characterize the different physiological states of normal/neoplastic tissue. Studies determining cell proliferation/apoptotic rates in target tissues exposed to DES have given further insights into mechanisms of DES-toxic effects. Effects of Tamoxifen and genistein on developing estrogen target tissues are being studied and dysmorphology/neoplastic potential compared to DES. Carcinogens in NTP rodent bioassays are being tested for estrogenic potency and compared in multiple bioassays. Sensitive markers of estrogenicity are being sought. These studies suggest a complex pattern of differentiation and development in hormone responsive target-tissues and provide important clues for mechanisms involved in the development of neoplasia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES070060-23
Application #
2574439
Study Section
Special Emphasis Panel (TB)
Project Start
Project End
Budget Start
Budget End
Support Year
23
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Adewale, Heather B; Jefferson, Wendy N; Newbold, Retha R et al. (2009) Neonatal bisphenol-a exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin-releasing hormone neurons. Biol Reprod 81:690-9
Newbold, Retha R; Jefferson, Wendy N; Padilla-Banks, Elizabeth (2009) Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117:879-85
Delclos, K Barry; Weis, Constance C; Bucci, Thomas J et al. (2009) Overlapping but distinct effects of genistein and ethinyl estradiol (EE(2)) in female Sprague-Dawley rats in multigenerational reproductive and chronic toxicity studies. Reprod Toxicol 27:117-32
Ruhlen, Rachel L; Howdeshell, Kembra L; Mao, Jiude et al. (2008) Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the ""fetal estrogenization syndrome"" and obesity in CD-1 mice. Environ Health Perspect 116:322-8
Tang, Wan-Yee; Newbold, Retha; Mardilovich, Katerina et al. (2008) Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149:5922-31
Newbold, Retha R; Padilla-Banks, Elizabeth; Jefferson, Wendy N et al. (2008) Effects of endocrine disruptors on obesity. Int J Androl 31:201-8
Newbold, Retha R (2008) Prenatal exposure to diethylstilbestrol (DES). Fertil Steril 89:e55-6
vom Saal, Frederick S; Akingbemi, Benson T; Belcher, Scott M et al. (2007) Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24:131-8
Newbold, Retha R; Jefferson, Wendy N; Padilla-Banks, Elizabeth (2007) Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24:253-8
Chen, Ying; Jefferson, Wendy N; Newbold, Retha R et al. (2007) Estradiol, progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in the neonatal mouse ovary in vitro and in vivo. Endocrinology 148:3580-90

Showing the most recent 10 out of 57 publications